Meet-the-Professor Session:
103. Secondary Prophylaxis in Immunosuppressed Stem Cell Transplant Recipients with a History of Invasive Mold Infection
Saturday, October 22, 2011: 7:00 AM-8:00 AM
Room: 151AB

Learning Objectives:

This program is directed to infectious diseases physicians, transplant specialists or others involved in management of opportunistic mold infections in the peritransplant period. It is assumed that audience participants know or are familiar with the basic epidemiology, risk factors, diagnosis  and current agents used for treatment of these infections. Upon completion of this session, the participant will be able to:

  • indentify strategies for pre-transplant risk assessment/evaluation of adequate treatment of invasive mold infection ( IMI)
  • review risk factors and monitoring approaches for IMI relapse
  • interpret cumulative literature about the role of new triazoles in secondary prophylaxis, including the role of antifungal drug monitoring

Target Audience: Researchers, Pharmacists, Nurses, Microbiologists, Lab Personnel, Investigators, Infectious Diseases Physicians, Infectious Diseases Pediatricians, Infection Preventionists, Hospital Epidemiologists, Health Care Workers, Fellows-in-Training, Epidemiologists, Clinicians, Academicians

Tracks: Adult ID

Meet-the-professors:  Lindsey Baden, MD, Brigham and Women's Hospital and Mindy Schuster, MD, University of Pennsylvania Medical Center


7:00 AM
Lindsey Baden, MD

7:20 AM
Mindy Schuster, MD

CME Credits: Maximum of 1.0 hours of Category 1 credit possible

ACPE Credits: ACPE 1.0 knowledge-based contact hours (0.1 CEU) of Pharmacy CE

ACPE Number: 0461-9999-11-155-L01-P


L. Baden, None

M. Schuster, None

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.